Gemini Therapeutics's market cap is currently ―. The company's EPS TTM is $-10.046; its P/E ratio is -1.98; Gemini Therapeutics is scheduled to report earnings on March 27, 2023, and the estimated EPS forecast is $-5.90. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -3.24M	$ -7.04M	$ -15.16M	$ -17.74M	$ -18.45M
EBITDA	$ -3.24M	$ -7.04M	$ -15.16M	$ -17.69M	$ -18.39M
Net Income Common Stockholders	$ -3.28M	$ -7.09M	$ -15.23M	$ -17.82M	$ -18.55M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 101.74M	$ 108.66M	$ 119.06M	$ 136.63M	$ 150.07M
Total Assets	$ 106.03M	$ 113.33M	$ 124.28M	$ 140.44M	$ 155.53M
Total Debt	$ 0.00	$ 2.91M	$ 4.16M	$ 5.40M	$ 6.65M
Net Debt	$ -101.74M	$ -105.75M	$ -114.91M	$ -131.22M	$ -143.42M
Total Liabilities	$ 1.46M	$ 6.44M	$ 12.67M	$ 15.60M	$ 14.67M
Stockholders Equity	$ 104.57M	$ 106.90M	$ 111.61M	$ 124.84M	$ 140.86M
Cash Flow	-
Free Cash Flow	$ -4.01M	$ -9.50M	$ -16.34M	$ -12.68M	$ -16.16M
Operating Cash Flow	$ -4.01M	$ -9.50M	$ -16.34M	$ -12.67M	$ -16.10M
Investing Cash Flow	-	-	-	$ 405.00K	-
Financing Cash Flow	$ -2.91M	$ -1.23M	$ -1.23M	$ -1.18M	$ -1.25M

Currency in USD

Gemini Therapeutics Earnings and Revenue History

Income Statement >

Gemini Therapeutics Debt to Assets

Balance Sheet >

Gemini Therapeutics Cash Flow

Cash Flow >

Gemini Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing